symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
RTGN,4.49,0,4,77551729,0,3.0-20.0,1.49,RetinalGenix Technologies Inc.,USD,0001836295,,,Other OTC,OTC,Medical Devices,https://retinalgenix.com,"RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is headquartered in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.",Dr. Jerry  Katzman,Healthcare,US,,415 578 9583,1450 North Mcdowell Boulevard,Petaluma,CA,94954,,0,https://financialmodelingprep.com/image-stock/RTGN.jpg,2022-02-24,False,False,False,False,False
